Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mDCF in Metastatic Esophageal, Gastroesophageal, and Gastric Cancer
NCT01715233Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Dec 2012
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in esophageal cancer, gastroesophageal junction cancer, gastric cancer (GC), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Dec 2012; status: completed.
02
Drugs
docetaxel
03
Conditions
esophageal cancergastroesophageal junction cancergastric cancer (GC)
Beyond the preview
Go deeper on NCT01715233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01715233.